The use of colchicine as an anti-inflammatory agent for stroke prevention in patients with coronary artery disease: a systematic review and meta-analysis
ConclusionsThe use of colchicine reduces the risk of stroke in patients with a history of coronary artery disease, without a significant increase in gastrointestinal and myopathy/myalgia adverse effects.
Source: Journal of Thrombosis and Thrombolysis - Category: Hematology Source Type: research
More News: Cardiology | Cardiovascular | Colchicine | Colcrys | Gastroenterology | Heart | Heart Attack | Hematology | Statistics | Stroke | Study | Thrombosis